BiomX (PHGE) Receivables (2021 - 2025)
BiomX (PHGE) posted Receivables of $280000.0 for Q3 2025, down 69.23% sequentially from $910000.0 in Q2 2025, and down 70.53% YoY from $950000.0 in Q3 2024.
BiomX (PHGE) Receivables (2021 - 2025) Analysis & Trends
BiomX has reported Receivables for 5 years, with the latest figure at $280000.0 in Q3 2025.
- Quarterly Receivables fell 70.53% year-over-year to $280000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $280000.0 (down 70.53% YoY) and the FY2024 annual result came in at $1.2 million, up 104.01% from the prior year.
- Receivables eased to $280000.0 in Q3 2025 per PHGE's latest filing, from $910000.0 in the prior quarter.
- Over five years, Receivables peaked at $1.2 million in Q1 2025 and troughed at $280000.0 in Q3 2025.
- A 5-year average of $800000.0 and a median of $888000.0 in 2021 frame the typical range for Receivables.
- The sharpest annual moves came in 2024 and 2025: Receivables surged 104.01% in 2024, then plunged 70.53% in 2025.
- Over 5 years, Receivables stood at $888000.0 in 2021, then tumbled by 36.15% to $567000.0 in 2022, then grew by 1.23% to $574000.0 in 2023, then soared by 104.01% to $1.2 million in 2024, then tumbled by 76.09% to $280000.0 in 2025.
- According to Business Quant data, Receivables over the past three periods registered $280000.0, $910000.0, and $1.2 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 160.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.06 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 912.74 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 215.33 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.09 Bn |
| 10 | BiomX | 361,408.40 | -806,591.60 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 280,000.00 |
| Jun 30, 2025 | 910,000.00 |
| Mar 31, 2025 | 1.24 Mn |
| Dec 31, 2024 | 1.17 Mn |
| Sep 30, 2024 | 950,000.00 |
| Jun 30, 2024 | 623,000.00 |
| Dec 31, 2023 | 574,000.00 |
| Dec 31, 2022 | 567,000.00 |
| Dec 31, 2021 | 888,000.00 |